13F
← All fund report cards

Creative Planning

13F equity value
$147.4B
Positions
4,076
Top 10 concentration
41.9%
Quarters / total new picks
32 / 3,305
13F equity value over time
$0M$74B$147B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 59.4% of quarters (excess t = 1.79, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+2.2%
t-stat
1.79
Quarterly win rate
59%
Annualized excess
+2.5%
$1 → follow vs universe
$2.50 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.04120180630: follow 0.95720180930: follow 0.97020181231: follow 0.94520190331: follow 0.91020190630: follow 0.94320190930: follow 1.00420191231: follow 0.81520200331: follow 1.07320200630: follow 1.19720200930: follow 1.52420201231: follow 1.52220210331: follow 1.57420210630: follow 1.73320210930: follow 1.58220211231: follow 1.34520220331: follow 1.43220220630: follow 1.33520220930: follow 1.42720221231: follow 1.32920230331: follow 1.42420230630: follow 1.38820230930: follow 1.57020231231: follow 1.65020240331: follow 1.71320240630: follow 1.89620240930: follow 1.89920241231: follow 1.71120250331: follow 1.93620250630: follow 2.00720250930: follow 2.30720251231: follow 2.499 0.75 1.72 2.70 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 4076 · 2026 Q1

Ticker Value Weight QoQ
IVV $15.7B
10.6%
ADD
BND $8.9B
6.1%
ADD
VEA $7.7B
5.2%
TRIM
SPDW $6.1B
4.1%
ADD
SPMD $5.7B
3.9%
ADD
IEMG $5.4B
3.7%
HOLD
VV $3.7B
2.5%
HOLD
AAPL $3.1B
2.1%
ADD
BSV $2.9B
2.0%
ADD
SPYM $2.6B
1.8%
ADD
VO $2.4B
1.6%
HOLD
AVDV $2.4B
1.6%
ADD
NVDA $2.4B
1.6%
ADD
VCIT $2.2B
1.5%
HOLD
AVUV $2.2B
1.5%
ADD
SCHX $2.1B
1.4%
HOLD
VTI $2.0B
1.3%
HOLD
XLRE $2.0B
1.3%
ADD
SPY $1.9B
1.3%
HOLD
DFAS $1.9B
1.3%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.